TMC435 for the treatment of chronic hepatitis C

Author： Tanwar Sudeep   Trembling Paul M   Dusheiko Geoffrey M  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.8, 2012-08, pp. : 1193-1209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Taribavirin for the treatment of chronic hepatitis C

By Kearney Keith R   Thornton James J   Navarro Victor J  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3243-3249

Informa Healthcare

Access to resources Recommend Favorite

Simeprevir for the treatment of chronic hepatitis C

By You David M   Pockros Paul J  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2581-2589

Informa Healthcare

Access to resources Recommend Favorite

Developments in the treatment of chronic hepatitis C

By Pockros Paul J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 515-528

Informa Healthcare

Access to resources Recommend Favorite

Metabolic alterations and chronic hepatitis C: treatment strategies

By Adinolfi Luigi E   Restivo Luciano   Zampino Rosa   Lonardo Amedeo   Loria Paola  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2215-2234

Informa Healthcare

Access to resources Recommend Favorite

New Therapies for the Treatment of Chronic Hepatitis C

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 959-966

Bentham Science Publishers

Access to resources Recommend Favorite